Second Alzheimer’s drug in the pipeline promises to slow worsening but with safety concern

Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening – by about four to seven months, researchers reported Monday.

Source: washingtontimes.com

Please follow and like us: